US Oncology Financial Analyst Salary | Comparably
US Oncology operates a network of integrated community-based oncology practices that provides cancer care services in the United States. read more
EMPLOYEE
PARTICIPANTS
79
TOTAL
RATINGS
549

US Oncology Financial Analyst Salary

The average US Oncology Financial Analyst earns an estimated $107,618 annually, which includes an estimated base salary of $80,862 with a $26,756 bonus. US Oncology's Financial Analyst compensation is $20,218 more than the US average for a Financial Analyst. Financial Analyst salaries at US Oncology can range from $56,000 - $310,000.

The Finance Department at US Oncology earns $35,238 more on average than the Admin Department.

Last updated 3 months ago.

$22k
$41k
$62k
$82k
$180k
$310k
$375k
$107,618
Average Compensation
$80,862
avg. base
$26,756
avg. bonus

Financial Analyst Salaries at US Oncology

Financial Analysts earn $5,482 more than Senior Accountants, and $13,609 less than Accounting Managers.

Accounting Manager
$121k*
Senior Accountant
$102k*
Financial Analyst
$101k*
Business Analyst
$87k*
Accountant
$71k*
* estimated salary

Compensation at US Oncology by Department

The Finance Department averages $35,238 more than the Admin Department, and $19,647 less than the IT Department

IT
$105,067 Avg. total comp.
+$20k
Finance
$85,420 Avg. total comp.
Admin
$50,182 Avg. total comp.
-$35k

Financial Analyst Compensation by Gender (All Companies)

The average female Financial Analyst at companies similar size to US Oncology reported making $93,556, while the average male Financial Analyst at similar sized companies reported making $91,853.

Financial Analyst Compensation by Ethnicity (All Companies)

The average Asian or Pacific Islander Financial Analyst at companies similar size to US Oncology reported making $98,729, while the average Native American Financial Analyst at similar sized companies reported making $60,000.

How Financial Analysts at US Oncology Rate Their Compensation

The majority of Financial Analysts at US Oncology believe they're compensated fairly. 50% of Financial Analysts at US Oncology say they receive annual bonuses, and the majority (60%) are satisfied with their benefits. See more compensation ratings at US Oncology

×
Rate your company